Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)
Egypt flag Egypt · Delayed Price · Currency is EGP
156.52
+1.97 (1.27%)
At close: Apr 2, 2026

EGX:MPCI Income Statement

Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Revenue
1,5191,508871.91663.83551.26518.11
1,5191,508871.91663.83551.26518.11
Revenue Growth (YoY)
23.45%72.93%31.34%20.42%6.40%6.08%
Cost of Revenue
954.13827.82571.62450.88401.87353.14
Gross Profit
564.39679.98300.29212.95149.39164.98
Selling, General & Admin
107.7499.0286.1977.4171.875.98
Other Operating Expenses
3558.612.6939.658.5554.86
Operating Expenses
142.74157.6388.88117.0680.35130.84
Operating Income
421.65522.35211.4195.8969.0434.13
Interest Expense
-11.69-13.51-14.26---
Interest & Investment Income
86.8136.4755.6511.137.285.41
Currency Exchange Gain (Loss)
----0.67-
Other Non Operating Income (Expenses)
4.756.56-23.292.961.342.11
EBT Excluding Unusual Items
501.52651.87229.52109.9878.3241.65
Gain (Loss) on Sale of Assets
0.440.44----
Pretax Income
501.95652.3229.52109.9878.3241.65
Income Tax Expense
114.75147.0238.0619.554.23-0.15
Net Income
387.2505.28191.4690.4474.0941.81
Net Income to Common
387.2505.28191.4690.4474.0941.81
Net Income Growth
2.80%163.91%111.70%22.07%77.22%140.14%
Shares Outstanding (Basic)
-23666-
Shares Outstanding (Diluted)
-23666-
Shares Change (YoY)
-304.44%----
EPS (Basic)
-22.2134.0416.0813.17-
EPS (Diluted)
-22.2134.0416.0813.17-
EPS Growth
--34.75%111.70%22.07%--
Free Cash Flow
-103.1365.65158.8346.4923.551.4
Free Cash Flow Per Share
-2.8928.248.274.19-
Dividend Per Share
13.18713.1874.0002.000--
Dividend Growth
229.67%229.67%100.00%---
Gross Margin
37.17%45.10%34.44%32.08%27.10%31.84%
Operating Margin
27.77%34.64%24.25%14.45%12.52%6.59%
Profit Margin
25.50%33.51%21.96%13.62%13.44%8.07%
Free Cash Flow Margin
-6.79%4.35%18.22%7.00%4.27%0.27%
EBITDA
441.87542.17223.59103.6576.6843.88
EBITDA Margin
29.10%35.96%25.64%15.61%13.91%8.47%
D&A For EBITDA
20.2219.8212.187.757.649.74
EBIT
421.65522.35211.4195.8969.0434.13
EBIT Margin
27.77%34.64%24.25%14.45%12.52%6.59%
Effective Tax Rate
22.86%22.54%16.58%17.77%5.40%-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.